Suzhou Zelgen Biopharmaceuticals Co., Ltd. (SHA:688266)

China · Delayed Price · Currency is CNY

98.80

-2.70 (-2.66%)

Apr 17, 2026, 3:00 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Pharmaceuticals	810.48M	532.95M	386.44M	302.31M	190.36M
Pharmaceuticals Growth	52.07%	37.91%	27.83%	58.81%	588.19%
Total	810.48M	532.95M	386.44M	302.31M	190.36M
Total Growth	52.07%	37.91%	27.83%	58.81%	588.19%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	802.64M	-	386.44M	302.31M	-
China Growth	-	-	27.83%	-	-
Overseas	7.55M	-	-	-	-
Total	810.19M	-	386.44M	302.31M	-
Total Growth	-	-	27.83%	-	-

Source: S&P Global Market Intelligence.